PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perylene-3,4:9,10-tetracarboxylic dianhydride | 204-905-3 | 128-69-8 | - | - | 1 | - | - | - | - | - | - | Details |
| 1,4-bis(p-tolylamino)anthraquinone | 204-909-5 | 128-80-3 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Pyrene | 204-927-3 | 129-00-0 | - | 1 | - | - | 1 | - | 1 | - | - | Details |
| Endo-3,6-methylene-1,2,3,6-tetrahydrophthalic anhydride | 204-957-7 | 129-64-6 | - | - | - | - | 1 | - | - | - | - | Details |
| N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline | 204-961-9 | 129-73-7 | - | - | - | - | - | 1 | - | - | - | Details |
| Dimethyl phthalate | 205-011-6 | 131-11-3 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Bis(1-methylheptyl) phthalate | 205-014-2 | 131-15-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Dipropyl phthalate | 205-015-8 | 131-16-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Diallyl phthalate | 205-016-3 | 131-17-9 | 1 | - | 2 | - | 1 | - | - | - | - | Details |
| Dipentyl phthalate | 205-017-9 | 131-18-0 | - | - | - | - | 1 | - | 1 | 1 | - | Details |
| 2,2',4,4'-tetrahydroxybenzophenone | 205-028-9 | 131-55-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 2,4-dihydroxybenzophenone | 205-029-4 | 131-56-6 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Oxybenzone | 205-031-5 | 131-57-7 | 1 | - | 1 | 1 | 1 | - | - | - | - | Details |
| Sodium 2-biphenylate | 205-055-6 | 132-27-4 | - | - | - | - | - | 1 | - | - | - | Details |
| 1-naphthylacetonitrile | 205-078-1 | 132-75-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Captan | 205-087-0 | 133-06-2 | - | - | - | - | - | 1 | - | - | - | Details |
| N-(trichloromethylthio)phthalimide | 205-088-6 | 133-07-3 | - | - | - | - | - | 1 | - | - | - | Details |
| Diethyl butylmalonate | 205-089-1 | 133-08-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Diethyl ethylmalonate | 205-093-3 | 133-13-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Bis(2,4-dichlorobenzoyl) peroxide | 205-094-9 | 133-14-2 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Disodium 4,4'-bis[(4,6-dianilino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate | 205-117-2 | 133-66-4 | 1 | - | 2 | - | 1 | - | - | - | - | Details |
| 2-ethoxybenzoic acid | 205-130-3 | 134-11-2 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Bis(8-hydroxyquinolinium) sulphate | 205-137-1 | 134-31-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 1-naphthylamine | 205-138-7 | 134-32-7 | - | - | - | - | 1 | - | - | - | - | Details |
| N,N-diethyl-m-toluamide | 205-149-7 | 134-62-3 | - | - | - | - | - | 1 | - | - | - | Details |